本页面由Tiger Trade Technology Pte. Ltd.提供服务

Travere Therapeutics, Inc.

40.95
-1.1800-2.80%
盘后40.68-0.2700-0.66%19:23 EDT
成交量:452.31万
成交额:1.86亿
市值:37.77亿
市盈率:-143.01
高:42.66
开:42.34
低:40.40
收:42.13
52周最高:43.31
52周最低:13.88
股本:9,224.16万
流通股本:9,122.00万
量比:0.97
换手率:4.96%
股息:- -
股息率:- -
每股收益(TTM):-0.2864
每股收益(LYR):-0.2864
净资产收益率:-57.80%
总资产收益率:-6.55%
市净率:32.90
市盈率(LYR):-143.01

数据加载中...

2025/12/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/30

重要事件披露

Form 8-K - Current report
2025/10/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/10

重要事件披露

Form 8-K - Current report
2025/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/06

重要事件披露

Form 8-K - Current report
2025/06/17

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/05/16

重要事件披露

Form 8-K - Current report